Crescendo Bioscience Garners $28,000,000 Series D Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=60d06187-b95d-4196-bbd4-2957fce9eebd&Preview=1 -
Date
1/3/2013 -
Company Name
Crescendo Bioscience -
Mailing Address
341 Oyster Point Blvd South San Francisco, CA 94080 -
Company Description
Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases. -
Website
http://www.crescendobio.com -
Transaction Type
Venture Equity -
Transaction Amount
$28,000,000 -
Transaction Round
Series D -
Proceeds Purposes
This round of funding will enable Crescendo to accelerate its commercialization efforts for Vectra DA, a novel test which assesses disease activity in rheumatoid arthritis patients. -
M&A Terms
-
Venture Investor
Skyline Ventures -
Venture Investor
Safeguard Scientifics -
Venture Investor
Mohr Davidow Ventures -
Venture Investor
Kleiner Perkins Caufield & Byers -
Venture Investor
Aeris Capital AG
